宝利国际(300135) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was ¥244,943,658.10, a decrease of 24.29% compared to ¥323,540,810.15 in the same period last year[3] - The net profit attributable to shareholders was -¥24,425,418.30, representing a decline of 40.68% from -¥17,362,684.14 in the previous year[3] - The net profit for Q1 2022 was -25,027,150.66 CNY, compared to -18,721,960.44 CNY in Q1 2021, representing an increase in net loss of approximately 33.5%[18] - Total operating revenue decreased to 399,700,097.47 CNY in Q1 2022 from 448,027,176.37 CNY in Q1 2021, a decline of about 10.8%[22] - The total operating profit was -23,816,084.97 CNY in Q1 2022, worsening from -14,455,624.91 CNY in Q1 2021, an increase in loss of approximately 64.7%[18] - The company reported a total comprehensive loss of -25,369,827.06 CNY in Q1 2022, compared to -18,322,507.23 CNY in Q1 2021, reflecting a worsening of about 38.5%[19] - Basic and diluted earnings per share were both -0.0265 CNY in Q1 2022, compared to -0.0188 CNY in Q1 2021, indicating a decline in earnings performance[19] Cash Flow and Liquidity - The net cash flow from operating activities was -¥51,508,940.48, a significant decrease of 762.32% compared to ¥7,777,067.12 in the same period last year[3] - Cash and cash equivalents at the end of Q1 2022 were 228,066,503.54 CNY, down from 364,760,476.04 CNY at the end of Q1 2021, a decrease of approximately 37.4%[23] - The company's cash and cash equivalents decreased by 56.85% to -¥127,592,552.32 from -¥81,344,593.74 in the previous year[8] - Investment activities resulted in a net cash outflow of -55,702,351.32 CNY in Q1 2022, compared to -63,551,259.61 CNY in Q1 2021, indicating a slight improvement[22] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,484,187,516.65, an increase of 2.52% from ¥2,423,159,512.52 at the end of the previous year[3] - Total liabilities increased to CNY 1,350,921,794.87 from CNY 1,264,523,963.69, marking a rise of 6.8%[14] - The company’s total liabilities increased, leading to a higher financial leverage, which may impact future financing and operational strategies[22] - The company's equity attributable to shareholders decreased to CNY 1,145,193,964.22 from CNY 1,169,962,058.92, a decline of 2.1%[15] Research and Development - Research and development expenses decreased by 49.00% to ¥4,454,380.48 from ¥8,734,644.94 in the previous period[8] - Research and development expenses for Q1 2022 were CNY 4,454,380.48, down 48.9% from CNY 8,734,644.94 in the previous year[17] Income and Other Gains - The company reported a significant increase in non-operating income from government subsidies, which rose by 113.14% to ¥1,559,416.97 compared to ¥731,627.19 in the previous year[8] - The company experienced a 2205.25% increase in asset disposal income, amounting to ¥8,227,236.87, up from ¥356,891.24 in the previous period[8] Accounts Receivable and Inventory - Accounts receivable decreased to CNY 285,999,107.47 from CNY 397,851,603.52, reflecting a reduction of 28.1%[13] - Inventory increased significantly to CNY 333,200,872.58, up 61.8% from CNY 206,078,810.14 at the beginning of the year[13] Credit and Impairment Loss - The company incurred a credit impairment loss of 4,091,952.80 CNY in Q1 2022, compared to 2,166,297.56 CNY in Q1 2021, an increase of about 89.0%[18]